AID Genomics

Improving people's lives by making genomic medicine accessible.

Healthcare & Life Sciences
Acquired by Aid Partners Capital Holdings
Pre-Funding Rehovot, Israel Founded 2018
Last updated 2026-09-06
Total raised
$25.2M
Stage
Pre-Funding
Founded
2018
Headcount
150
HQ
Rehovot, Israel
Sector
Healthcare & Life Sciences

About

AID Genomics is a research and development-driven diagnostic company focused on developing precision medicine-based diagnostic solutions primarily for oncology, but also for hereditary rare diseases and infectious diseases. The company aims to provide accurate diagnostics to patients and physicians, enabling better treatment choices. They combine cutting-edge technologies such as next-generation sequencing (NGS), miRNA, epigenetics, and AI-based analytical tools. Established in 2018, AID Genomics acquired Rosetta microRNA patents in the same year for the development of microRNA-based tests. In 2020, AID Genomics was contracted by the Israeli Government to revamp six laboratories and provide COVID-19 PCR testing, building a highly automated laboratory in Jerusalem.

Funding history · 2 rounds · $25.2M total

2 events/rounds · $25.2M Total Funding: $25.2M in Private Equity
2017
Pre-Seed $23.0M globes.co.il ↗
★ AID Partners
Date unknown
Seed $2.2M pitchbook.com

Headcount over time

150 employees (2026-09) · 1 point
150 150 2026-09

Offices

Rehovot, Israel · HQ / main office
Show all offices (1 more)
  • Hong Kong

Q&A

What is AID Genomics' primary focus?
AID Genomics is a research and development-driven diagnostic company focused on developing precision medicine-based diagnostic solutions, primarily for oncology, hereditary rare diseases, and infectious diseases.
When was AID Genomics founded?
AID Genomics was founded in July 2018.
Where is AID Genomics headquartered?
AID Genomics is headquartered in Rehovot, Israel.
What is the employee count of AID Genomics?
AID Genomics has 51–200 employees.
What technologies does AID Genomics utilize in its R&D?
AID Genomics' R&D division combines cutting-edge technologies such as next-generation sequencing, miRNA, epigenetics, and AI-based analytical tools.
What is AID Genomics' current funding stage?
AID Genomics is currently in the Pre-Funding stage.
Is AID Genomics part of a larger group?
Yes, AID Genomics is a member of the AID Private Equity Group.
Does AID Genomics hold any patents?
Yes, AID Genomics holds 1 patent.

Team · 9

Kelvin Wu
Founder · Executive Chairman and Co-Founder
Snir Zano
Founder · Chief Executive Officer and Co-Founder
Izhak Haviv
Founder · Chief Scientific Officer
Shimon Gross
Executive VP, Genomics
Itai Cohen
Chief Financial Officer
Dor Sultan
Chief Marketing Officer
Asaf Gertler
VP Clinical Affairs
Yannay Ramot
Chief Operations Officer
Andrew Rickards
Director

Sectors & technology

Primary sector
Healthcare & Life Sciences
Technologies
Target customers
Business model
B2BB2C

Highlights

1 PatentsVerified

Tags

patientsgenomicsdigital-healthcarediagnosticscancerbioinformaticspersonalizationbiotechnologypersonalized-medicinetreatmentsearly-detection
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteaidgenomics.com/
LinkedInlinkedin.com/company/33242362
Facebookfacebook.com/AID-Genomics-115066810237463

Identifiers & details

Legal nameAID Genomics Ltd.
Founded2018
Employees (exact)150
OfficesHong Kong

Acquisitions & public offerings

Acquired by Aid Partners Capital Holdings 2017-05 $23.0M

Radar intelligence

Patents

EPO3

Web history (Wayback)

Domainaidgenomics.com

Certificate / subdomain footprint

Subdomains26

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515882884
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2018-07-31
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Last annual report2023
Active charges / liens0
Registry events1 — violation (1)
Registered addressהחרש 20 אשקלון

Recent registry events

DateEvent
2026-06-25עדכון הפרה